<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28234">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01669616</url>
  </required_header>
  <id_info>
    <org_study_id>VL-2723</org_study_id>
    <nct_id>NCT01669616</nct_id>
  </id_info>
  <brief_title>Point of Service Diabetes Screening Evaluation</brief_title>
  <acronym>POSSE</acronym>
  <official_title>Point of Service Diabetes Screening Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VeraLight, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VeraLight, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the trial is to collect SCOUT DS, random capillary glucose and
      Hemoglobin A1c measurements from subject 18 years of age or older.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to compare the accuracy of SCOUT versus random capillary
      glucose and several diabetes risk assessment questionnaires for detection of HbA1C-defined
      dysglycemia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>To compare the accuracy of SCOUT DS versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1c-defined dysglycemia.</measure>
    <time_frame>one week</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">667</enrollment>
  <condition>Diabetes Mellitus, Non-Insulin Dependent</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Attendees of Blue Cross Blue Shield Wellness Event
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

        Exclusion Criteria:

          -  Known to be pregnant (self-reported)

          -  Receiving dialysis or known renal compromise

          -  Known to have photosensitivity

          -  Taking medications that fluoresce

          -  Have scars, any tattoos, rashes or other disruption/discoloration on the left volar
             forearm
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Barrack, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Blue Cross Blue Shield of Louisiana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Blue Cross Blue Shield of Louisiana</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 13, 2013</lastchanged_date>
  <firstreceived_date>July 23, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Adults 18 years and older</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
